Bertrand Liagre is an expert in Biochemistry at University of Limoges (France). Bertrand Liagre has authored 121 publications, the most recent in 2026. SLR score: 276 (community average: 125). How the SLR is computed.

LeadR Profile

Bertrand Liagre University of Limoges France
276 ScienceLeadR Reputation 276
Network Map

Biochemistry

Subspecialties: Oncology - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1997 - 2026

Source: PubMed

University of Limoges

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 121

Citations

Citations: 3 588 1st author: 9 Last author: 27 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Ent-Atisane and 3,4-seco-atisane diterpenoids from Croton crocodilorum roots and their antiproliferative effect on human colorectal cancer cells.
PMID 41985850 — cells, diterpenes, pharmaceutical preparations, neoplasms, colorectal neoplasms
Fitoterapia20260
Neutrophils and Neutrophil-Based Drug Delivery Systems in Anti-Cancer Therapy.
PMID 40227814 — cells, growth, vascular endothelial growth factor a, pharmaceutical preparations, neoplasms, phenotype, neutrophils, immunotherapy, neoplasm metastasis, drug delivery systems, therapeutics, tumor microenvironment
Cancers (Basel)20250
Synthesis of long-wavelength-absorbing photosensitizer/nanoparticle conjugates and their in vitro PDT evaluation on colorectal cancer cell lines
OpenAlex W4408163450 — cells, nanoparticles, neoplasms, photosensitizing agents, cell line, colorectal neoplasms
C R Chim20250
Photodynamic anti-cancer therapy and arachidonic acid metabolism: State of the art in 2024.
PMID 40020873 — cells, arachidonic acid, neoplasms, photosensitizing agents, pharmacology, therapeutics
Ann Pharm Fr20250
Curcumin-Based Nanoparticles: Advancements and Challenges in Tumor Therapy.
PMID 39861761 — biological availability, nanoparticles, neoplasms, curcumin, research, therapeutics, apoptosis
Pharmaceutics20256

LeadR Networks

Main global connection map